Meta-Analysis Evaluating the Impact of Site of Metastasis on Overall Survival in Men With Castration-Resistant Prostate Cancer
about
Bone imaging in prostate cancer: the evolving roles of nuclear medicine and radiologyMETastasis Reporting and Data System for Prostate Cancer: Practical Guidelines for Acquisition, Interpretation, and Reporting of Whole-body Magnetic Resonance Imaging-based Evaluations of Multiorgan Involvement in Advanced Prostate Cancer.Impact of intense systemic therapy and improved survival on the use of palliative radiotherapy in patients with bone metastases from prostate cancer.c-MYC drives histone demethylase PHF8 during neuroendocrine differentiation and in castration-resistant prostate cancer.68Ga-PSMA-11 PET/CT for prostate cancer staging and risk stratification in Chinese patients.Efficacy of Cabazitaxel Treatment in Metastatic Castration Resistant Prostate Cancer in Second and Later Lines. An Experience from Two German CentersA new model of multi-visceral and bone metastatic prostate cancer with perivascular niche targeting by a novel endothelial specific adenoviral vector.Cellular determinants and microenvironmental regulation of prostate cancer metastasis.The Role of Testosterone in the Treatment of Castration-Resistant Prostate Cancer.Expression of STAT3 in Prostate Cancer Metastases.Therapeutic management of bone metastasis in prostate cancer: an update.The Cohesive Metastasis Phenotype in Human Prostate Cancer.Emerging Variants of Castration-Resistant Prostate Cancer.Successful Yttrium-90 Microsphere Radioembolization for Hepatic Metastases of Prostate Cancer.The role of metastasis-directed therapy and local therapy of the primary tumor in the management of oligometastatic prostate cancer.Does T1- and diffusion-weighted magnetic resonance imaging give value-added than bone scintigraphy in the follow-up of vertebral metastasis of prostate cancer?The outcome of prostate cancer patients treated with curative intent strongly depends on survival after metastatic progression.Multiparametric Magnetic Resonance Imaging of Prostate Cancer Bone Disease: Correlation With Bone Biopsy Histological and Molecular Features.Preliminary results on response assessment using 68Ga-HBED-CC-PSMA PET/CT in patients with metastatic prostate cancer undergoing docetaxel chemotherapy.Radium-223 dichloride for the treatment of castration-resistant prostate cancer with symptomatic bone metastases.CTC-derived AR-V7 detection as a prognostic and predictive biomarker in advanced prostate cancer.Drug-drug interaction potential in men treated with enzalutamide: Mind the gap.Bone biopsy protocol for advanced prostate cancer in the era of precision medicine.Imaging αvβ3 integrin expression in skeletal metastases with 99mTc-maraciclatide single-photon emission computed tomography: detection and therapy response assessment.A prognostic model for stratifying clinical outcomes in chemotherapy-naive metastatic castration-resistant prostate cancer patients treated with abiraterone acetate.Laboratory-Based Biomarkers and Liver Metastases in Metastatic Castration-Resistant Prostate Cancer.Prognostic and predictive clinical factors in patients with metastatic castration-resistant prostate cancer treated with cabazitaxel.Usefulness of combined androgen blockade therapy with gonadotropin-releasing hormone antagonist for bone metastatic prostate cancer with pretreatment prostate-specific antigen level ≥ 50 ng/mL.High mobility group box 1 promotes the epithelial-to-mesenchymal transition in prostate cancer PC3 cells via the RAGE/NF-κB signaling pathway.Mechanisms and Approaches for Overcoming Enzalutamide Resistance in Prostate Cancer.
P2860
Q28071705-EC12B697-0298-4DDA-9BB0-7FB084E71137Q31108842-1A63D1D2-3844-41A5-A047-CF6B034FB106Q37288432-A0E5BE52-65A8-415D-B650-FB3A257A34E6Q37688990-DB461426-D384-41BC-8747-2795DAE770ABQ37707083-725E0196-A4F4-47F9-923B-68AFCE1381F4Q37726362-8E63748D-7B63-4B96-9292-CEEEB7E43679Q38720538-5C9EAF3C-B42B-4616-B050-C9733770B0ACQ38730590-2C983508-208D-43C6-B755-2C83CB697BC2Q38810776-567C3427-1B84-4F99-966B-62EA41B66E44Q38848519-11F8C244-538B-42B3-8C38-38A2CE7A3199Q38964037-FD32B52D-0528-4575-85AF-0AEAD64B350EQ38966462-676F37DE-3F76-4EA1-8843-A171C76D2979Q39210257-E04083CC-A73C-43F5-93B1-78698652F631Q41485921-5736C0E6-73E2-4063-BB98-20399E16E2EEQ41566002-17DA55A4-B29A-4873-AFFE-8A21DA83E7B9Q41566010-B303E2CD-F654-48B4-92B5-E072AF49E0DEQ41711657-3209B542-8E34-4CD0-82B5-72054A44E466Q42690512-54A0F8FB-F918-410F-8DF6-5182F705F75FQ47399411-60BA4D36-6946-4789-89E8-4918B3721A97Q47557622-150BAC7B-60CA-4546-AD14-0BE0C207842DQ47740995-7608D954-5B3A-4ABD-83F4-B6F417C4C9F6Q48109856-9EDDB68D-1B30-4C89-9B91-6F3080D8FD28Q48368518-EFCAA893-49C2-426F-BDF7-ED1FCDF6A4FBQ49357072-5F1C1506-FD36-4C17-A090-AD27263D6890Q49579799-54129479-9D68-4DA2-A00E-696EE595040DQ52560267-AFBB8853-2D03-4032-8544-720464D18ABBQ53822455-51BB4DA0-164F-4554-81EA-2FC091F22120Q55068843-3BD62B3E-B5F8-456D-8B3F-879219AD6737Q55307923-BF0CD9E8-6C8C-4EBA-9928-AB7242B830A8Q55331819-C9B87767-B130-4ABD-AC55-91375DB3CBD9
P2860
Meta-Analysis Evaluating the Impact of Site of Metastasis on Overall Survival in Men With Castration-Resistant Prostate Cancer
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Meta-Analysis Evaluating the I ...... tion-Resistant Prostate Cancer
@ast
Meta-Analysis Evaluating the I ...... tion-Resistant Prostate Cancer
@en
type
label
Meta-Analysis Evaluating the I ...... tion-Resistant Prostate Cancer
@ast
Meta-Analysis Evaluating the I ...... tion-Resistant Prostate Cancer
@en
prefLabel
Meta-Analysis Evaluating the I ...... tion-Resistant Prostate Cancer
@ast
Meta-Analysis Evaluating the I ...... tion-Resistant Prostate Cancer
@en
P2093
P2860
P356
P1476
Meta-Analysis Evaluating the I ...... tion-Resistant Prostate Cancer
@en
P2093
Abderrahim Fandi
Andrew J Armstrong
Catherine M Tangen
Celestia S Higano
Christopher J Logothetis
Daniel P Petrylak
David I Quinn
Eric J Small
Haojin Zhou
P2860
P304
P356
10.1200/JCO.2015.65.7270
P407
P577
2016-03-07T00:00:00Z